Funding Rounds
ReViral

ReViral Series C (2020, $44M)

ReViral

Biotechnology firm developing antiviral treatments for patients.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series C

Raised Amount: $44.00M

Raised Date: 2020-01-01

Investors